An open label study to investigate the pharmacokinetics (PK) of ebastine in patients with liver impairment compared with healthy volunteers.

被引：0

作者：

Vargas, R

Semiond, D

Sanderink, G

Noveck, R

McMahon, FG

Lasseter, K

Gillen, M

Davidson, J

DePhillips, S

Rao, Z

机构：

[1] Rhone Poulenc Rorer, Collegeville, PA USA

[2] Clin Pharacol Associates, Miami, FL USA

[3] Clin Res Ctr, New Orleans, LA USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2000年 / 67卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PI33

引用

页码：97 / 97

页数：1

共 50 条

[1] Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers - A phase I open-label study
Lasseter, KC
Dilzer, SC
Vargas, R
Waldman, S
Noveck, RJ
[J]. CLINICAL PHARMACOKINETICS, 2004, 43 (02) : 121 - 129
[2] Repaglinide pharmacokinetics in patients with renal impairment versus healthy volunteers.
Ruckle, JL
Hatorp, V
[J]. DIABETOLOGIA, 1998, 41 : A235 - A235
[3] An open-label study on the pharmacokinetics (PK) of pitavastatin (NK-104) when administered concomitantly with fenofibrate or gemfibrozil in healthy volunteers.
Mathew, P
Cuddy, T
Tracewell, WG
Salazar, D
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P33 - P33
[4] Impact of demographic and clinical factors on the pharmacokinetics (PK) of sunitinib in patients and healthy volunteers.
Houk, B. E.
Kang, D.
Bello, C.
Cohen, D.
Poland, B.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S53 - S54
[5] STUDY ON PHARMACOKINETICS OF BIAPENEM IN HEALTHY VOLUNTEERS.
Shen, Q.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S32 - S32
[6] Pharmacokinetics and Safety of Ebastine in Patients with Impaired Hepatic Function Compared with Healthy VolunteersA Phase I Open-Label Study
Kenneth C. Lasseter
Stacy C. Dilzer
Ramon Vargas
Scott Waldman
Robert J. Noveck
[J]. Clinical Pharmacokinetics, 2004, 43 : 121 - 129
[7] Pharmacokinetics (PK) and pharmacodynamics (PD) of interferon β-1a in healthy volunteers.
Buchwalder, PA
Buclin, T
Trinchard, I
Munafo, A
Biollaz, J
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 166 - 166
[8] Concomitant pharmacokinetics (PK) of micafungin, an echinocandin antifungal, and cyclosporine in healthy volunteers.
Townsend, R
Hebert, M
Wisemandle, W
Bekersky, I
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1054 - 1054
[9] Concomitant pharmacokinetics (PK) of micafungin, an echinocandin antifungal, and tacrolimus in healthy volunteers.
Townsend, R
Hebert, M
Wisemandle, W
Bekersky, I
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1055 - 1055
[10] Pharmacokinetics (PK) and pharmacodynamics (PD) of a combination of tramadol (T) and acetaminophen (A) in healthy volunteers.
Rollason, V
Vogt, N
Deloche, C
Piguet, V
Dayer, R
Desmeules, J
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P52 - P52

← 1 2 3 4 5 →